Literature DB >> 20484303

Pulmonary alveolar proteinosis in a kidney transplant: a rare complication of sirolimus.

Huseyin Kadikoy1, Michael Paolini, Katafan Achkar, Wadi Suki, A Osama Gaber, Nabeel Anwar, Abdallah Jeroudi, Roberto Barrios, Abdul Abdellatif.   

Abstract

Pulmonary alveolar proteinosis (PAP) has been associated with the immunosuppressant sirolimus in transplant patients. PAP is a progressive lung disease characterized by the accumulation of surfactant-like material in the lungs leading to decreased pulmonary function with shortness of breath and cough as common symptoms. We report a rare case of sirolimus-associated PAP in a kidney transplant recipient with a history of end-stage renal disease secondary to haemolytic uraemic syndrome (HUS) and review of the literature. Discontinuation of sirolimus and initiation of tacrolimus led to resolution of PAP without recurrence of HUS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484303     DOI: 10.1093/ndt/gfq265

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

1.  Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens.

Authors:  Sean Kirby; Anjali Satoskar; Sergey Brodsky; Amy Pope-Harman; David Nunley; Charles Hitchcock; Ronald Pelletier; Patrick Ross; Tibor Nadasdy; Konstantin Shilo
Journal:  Diagn Pathol       Date:  2012-03-14       Impact factor: 2.644

2.  Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient.

Authors:  Ashfaq Hasan; Raja Ram; Tln Swamy
Journal:  Lung India       Date:  2014-07

Review 3.  Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature.

Authors:  Patricia Lopez; Sven Kohler; Seema Dimri
Journal:  J Transplant       Date:  2014-12-18

4.  Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis.

Authors:  Kamal Sewaralthahab; Helmut Rennke; Sarah Sewaralthahab; Nicolaos E Madias; Bertrand L Jaber
Journal:  Clin Nephrol Case Stud       Date:  2014-12-15

5.  Sirolimus-induced secondary pulmonary alveolar proteinosis.

Authors:  Stephanie Wang; Elinor Lee; Ryan Lau; Tisha Wang
Journal:  Respir Med Case Rep       Date:  2021-12-15

6.  Lung Transplant Recipient with Pulmonary Alveolar Proteinosis.

Authors:  Sofya Tokman; M Frances Hahn; Hesham Abdelrazek; Tanmay S Panchabhai; Vipul J Patel; Rajat Walia; Ashraf Omar
Journal:  Case Rep Transplant       Date:  2016-04-24

Review 7.  Beyond "Big Eaters": The Versatile Role of Alveolar Macrophages in Health and Disease.

Authors:  Miriam Hetzel; Mania Ackermann; Nico Lachmann
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.